NTRSO
NORTHERN TRUST CORP
$18.55
-0.46%
$3.4B
No data for this timeframe.
Vol
Market Cap$3.4B
Cap SizeMid Cap
SEC Reports3
Recent Activity
May 14, 2026
SEC
Northern Trust Corp filed its quarterly 13F-HR for the period ending March 31, 2026, reporting $756.6 billion in total h
13F-HR — Impact 4/10
Apr 21, 2026
SEC
Northern Trust disclosed its 2025 financial results during its annual meeting, showing a 2% decline in revenue and 11% d
8-K — Impact 5/10
Apr 21, 2026
SEC
Northern Trust reported Q1 2026 earnings with $525.5M net income and $2.71 diluted EPS, up 43% YoY, driven by strong rev
8-K — Impact 8/10
Analyst Ratings
3Strong Buy
5Buy
12Hold
2Sell
0Strong Sell
Latest Reports
NEUTRAL
13F-HR
4/10
Northern Trust Corp filed its quarterly 13F-HR for the period ending March 31, 2026, reporting $756.6 billion in total h
May 14, 2026
BEARISH
8-K
5/10
Northern Trust disclosed its 2025 financial results during its annual meeting, showing a 2% decline in revenue and 11% d
Apr 21, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 5.7/10.
NEUTRAL
13F-HR
4/10
Northern Trust Corp filed its quarterly 13F-HR for the period ending March 31, 2026, reporting $756.
May 14, 2026
BEARISH
8-K
5/10
Northern Trust disclosed its 2025 financial results during its annual meeting, showing a 2% decline
Apr 21, 2026
BULLISH
8-K
8/10
Northern Trust reported Q1 2026 earnings with $525.5M net income and $2.71 diluted EPS, up 43% YoY,
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 36% buy across 22 analysts — 3 strong buy, 5 buy, 12 hold, 2 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $2.2B | 10.8% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $2.2B | 7.6% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $8.8B | 8.9% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $9.2B | 3.7% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 12 | 2 | 0 | 36% | |
| May 1, 2026 | 3 | 5 | 12 | 2 | 0 | 36% | |
| Apr 1, 2026 | 1 | 2 | 13 | 4 | 2 | 14% | |
| Mar 1, 2026 | 1 | 2 | 13 | 4 | 2 | 14% | |
| Feb 1, 2026 | 1 | 2 | 13 | 4 | 2 | 14% | |
| Jan 1, 2026 | 1 | 2 | 13 | 4 | 2 | 14% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.